Diabetes, Vol 48, Issue 9 1863-1867, Copyright © 1999 by American Diabetes Association

ARTICLES

A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor

BD Mitchell, SA Cole, AG Comuzzie, L Almasy, J Blangero, JW MacCluer and JE Hixson
Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, Texas 78245-0549, USA. bmitchel@darwin.sfbr.org

The beta-3 adrenergic receptor (ADRB3) has been implicated as a regulator of energy expenditure, and a polymorphism in codon 64 of this gene (Trp64Arg) has been associated in some studies with obesity and insulin resistance. However, many studies have failed to detect an effect of this variant, and the importance of the Trp64Arg variant in human obesity remains controversial. We performed a quantitative linkage analysis of the ADRB3 and obesity, using 12 markers (including the intragenic Trp64Arg polymorphism) spanning a 57-cM region of chromosome 8. The study population consisted of 470 individuals from 10 large multigenerational families of Mexican-American ancestry residing in San Antonio, TX. In two-point analysis, logarithm of odds (LOD) scores >1.0 were observed for six markers surrounding ADRB3 in a 33-cM region spanned by markers D8S1477 and D8S1136. The multipoint LOD score was 3.21, occurring between markers D8S1121 and ADRB3, approximately 2-3 cM from ADRB3. Adjusting for the presence of the Arg64 allele or excluding from the analysis the 11 individuals homozygous for the Arg64 allele did not reduce the evidence for linkage. A genome scan was conducted at 10 cM map density to detect other loci influencing variation in BMI. Multipoint LOD scores >1.0 were observed in four other regions, including two on chromosome 17, one on chromosome 6q, and one on chromosome 2p. These data suggest that the ADRB3 should continue to be regarded as a strong candidate gene for obesity even though evidence for an effect of the Trp64Arg polymorphism could not be established. It is also possible that a gene closely linked to ADRB3 may influence susceptibility to obesity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. Yang, T. Kelly, and J. He Genetic Epidemiology of Obesity Epidemiol. Rev., June 12, 2007; (2007) mxm004v1. [Abstract] [Full Text] [PDF]

				C. J. Abularrage, A. N. Sidawy, G. Aidinian, N. Singh, J. M. Weiswasser, and S. Arora Evaluation of Macrocirculatory Endothelium-Dependent and Endothelium-Independent Vasoreactivity in Vascular Disease Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2005; 17(3): 245 - 253. [Abstract] [PDF]

				C. L. Avery, B. I. Freedman, G. Heiss, A. Kraja, T. Rice, D. Arnett, M. B. Miller, J. S. Pankow, C. E. Lewis, R. H. Myers, et al. Linkage Analysis of Diabetes Status Among Hypertensive Families: The Hypertension Genetic Epidemiology Network Study Diabetes, December 1, 2004; 53(12): 3307 - 3312. [Abstract] [Full Text] [PDF]

				M. M. Sale, B. I. Freedman, C. D. Langefeld, A. H. Williams, P. J. Hicks, C. J. Colicigno, S. R. Beck, W. M. Brown, S. S. Rich, and D. W. Bowden A Genome-Wide Scan for Type 2 Diabetes in African-American Families Reveals Evidence for a Locus on Chromosome 6q Diabetes, March 1, 2004; 53(3): 830 - 837. [Abstract] [Full Text] [PDF]

				A. Luke, X. Wu, X. Zhu, D. Kan, Y. Su, and R. Cooper Linkage for BMI at 3q27 Region Confirmed in an African-American Population Diabetes, May 1, 2003; 52(5): 1284 - 1287. [Abstract] [Full Text] [PDF]

				C. Szabo, A. Zanchi, K. Komjati, P. Pacher, A. S. Krolewski, W. C. Quist, F. W. LoGerfo, E. S. Horton, and A. Veves Poly(ADP-Ribose) Polymerase Is Activated in Subjects at Risk of Developing Type 2 Diabetes and Is Associated With Impaired Vascular Reactivity Circulation, November 19, 2002; 106(21): 2680 - 2686. [Abstract] [Full Text] [PDF]

				H. Corominola, L. J. Conner, L. S. Beavers, R. A. Gadski, D. Johnson, J. F. Caro, and R. Rafaeloff-Phail Identification of Novel Genes Differentially Expressed in Omental Fat of Obese Subjects and Obese Type 2 Diabetic Patients Diabetes, December 1, 2001; 50(12): 2822 - 2830. [Abstract] [Full Text] [PDF]

				R. P. Erickson and P. E. Graves Genetic Variation in {beta}-Adrenergic Receptors and Their Relationship to Susceptibility for Asthma and Therapeutic Response Drug Metab. Dispos., April 1, 2001; 29(4): 557 - 561. [Abstract] [Full Text]

				W.-C. Hsueh, S. A. Cole, A. R. Shuldiner, B. A. Beamer, J. Blangero, J. E. Hixson, J. W. MacCluer, and B. D. Mitchell Interactions Between Variants in the {beta}3-Adrenergic Receptor and Peroxisome Proliferator-Activated Receptor-{gamma}2 Genes and Obesity Diabetes Care, April 1, 2001; 24(4): 672 - 677. [Abstract] [Full Text]

				W.-C. Hsueh, B. D. Mitchell, J. L. Schneider, P. L. St. Jean, T. I. Pollin, M. G. Ehm, M. J. Wagner, D. K. Burns, H. Sakul, C. J. Bell, et al. Genome-Wide Scan of Obesity in the Old Order Amish J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1199 - 1205. [Abstract] [Full Text]

				A. H. Kissebah, G. E. Sonnenberg, J. Myklebust, M. Goldstein, K. Broman, R. G. James, J. A. Marks, G. R. Krakower, H. J. Jacob, J. Weber, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome PNAS, December 19, 2000; 97(26): 14478 - 14483. [Abstract] [Full Text] [PDF]